CVI Holdings’s BioCardia BCDA Stock Holding History

CVI Holdings’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,627	Closed	-$58K	–	87
2020 Q2	$58K	Buy	+1,627	New	+$88.1K	0.02%	61

Other funds holding BCDA

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CVI Holdings's BCDA Position: Q3 2020 in Review

CVI Holdings sold out of BioCardia (BCDA) in Q3 2020, closing a stake of 1,627 shares — an estimated $58K sold.

CVI Holdings first reported a position in BCDA in Q2 2020 and held it in 1 quarter. The position peaked at $58K in Q2 2020. 8 funds tracked by Wall St. Rank hold BCDA as of Q3 2020.

CVI Holdings reported no remaining BioCardia position as of Q3 2020 after selling out during the quarter.
CVI Holdings sold 1,627 BioCardia shares in Q3 2020, an estimated $58K.
CVI Holdings first reported a position in BioCardia in Q2 2020 and held it in 1 quarter.
CVI Holdings's BioCardia position peaked at $58K in Q2 2020.
8 funds tracked by Wall St. Rank held BioCardia as of Q3 2020.

Based on CVI Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.